CENTRE NATIONAL DE LA RECHERCHE SCIENTIRIQUE;ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIE;UNIVERSITE MONTPELLIER 1;UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES;UNIVERSITE PARIS-NORD 13;UNIVER
The use of compounds of formula (1) as defined in the description, for reducing or preventing the onset of metastases in a patient suffering from cancer. Pharmaceutical compositions for using in human or veterinary medicine, including at least one compound of formula (1) are also described.